Mutations in GPAT4, which encodes the enzyme glycerol-3-phosphate acyltransferase, are associated with various activities and may be a potential therapeutic target for the prevention and treatment of diseases related to energy metabolism,14 obesity, insulin resistance, and type 2 diabetes.47 The gene discussed is GPAT4; the disease is obesity due to melanocortin 4 receptor deficiency.